Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - TAX PROVISION
Tax Provision ALNY - Alnylam Pharmaceuticals, Inc.
6.72 M
LAST VALUE
214.48%
2 YEAR CAGR
52.22%
5 YEAR CAGR
16.22%
10 YEAR CAGR